Compugen Ltd. , a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe.
Compugen stock last closed at $2.08, up 1.46% from the previous day, and has increased 24.55% in one year. It has overperformed other stocks in the Biotechnology industry by 0.39 percentage points. Compugen stock is currently +84.07% from its 52-week low of $1.13, and -12.61% from its 52-week high of $2.38.
As of Mar 6, 2026, there are 94.55M shares of CGEN outstanding. The market capitalization of CGEN is $196.67M. In the past 24 hours, 191,000 CGEN shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy CGEN shares.
Based on our research, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, you'll need to fill out some personal info so you are able to buy CGEN today.
Now that you have created your account on the best stock trading app, your next step is to transfer the money for your investment:
Check out the video below for more details depositing money into your new investment account.
Once you have identified the best place to buy Compugen stock, it's absolutely critical to evaluate their stock before you invest, so you actually understand the risk as well as the opportunity.
WallStreetZen was created to help everyday investors perform better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on CGEN's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge CGEN's fair value.
Using relative valuations metrics:
You can access more valuation analysis on CGEN's stock here.
Out of 1 sell side analysts who give recommendations on CGEN, the consensus analyst rating on Compugen is a Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Compugen stock forecast page.
Last year, CGEN revenue was $72.76M. In the past 5 year, CGEN's revenue has gone up by 105.2% per year. This was faster than the Biotechnology industry average of 32.34%.
Learn more about CGEN's earnings and revenue performance here.
In the last year, executives and large shareholders at CGEN have not bought or sold any shares.
Learn more about who owns CGEN stock here.
No, Compugen doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
You have two main options:
Click the Open Trade button and your broker will place the order.
If you need more help buying stocks on eToro, watch the helpful video below:
Now that you own some shares in CGEN, you'll want to stay up-to-date on your new shares.
Make a watchlist to track the most important metrics related to your CGEN stock.
To summarize, here are the 6 steps to buy Compugen stock:
If you need a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get notifications regarding your new investment in Compugen, get started below.